MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20223198

April 8, 2022

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C16H28N2O4计)

化学药品

April 8, 2022

Company Information

Applicant Company

广东省东莞市松山湖园区工业北路1号

Manufacturing Company

广东省东莞市松山湖园区工业北路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath